Arthritis associated with Kawasaki disease: MRI findings and serum matrix metalloproteinase-3 profiles

被引：15
|
作者：
Izumi, Gaku [1 ,2 ]
Narugami, Masashi [2 ]
Saita, Yoshinori [2 ]
Matsuzawa, Tohru [3 ]
Sugawara, Osamu [4 ]
Kawamura, Nobuaki [1 ]
Kobayashi, Ichiro [1 ,2 ]
机构：
[1] Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido 0608638, Japan
[2] Kitami Red Cross Hosp, Dept Pediat, Kitami, Hokkaido, Japan
[3] Kitami Red Cross Hosp, Dept Radiol, Kitami, Hokkaido, Japan
[4] Kitami Red Cross Hosp, Dept Orthoped, Kitami, Hokkaido, Japan
来源：
PEDIATRICS INTERNATIONAL | 2011年 / 53卷 / 06期
关键词：
arthritis; Kawasaki disease; magnetic resonance imaging; matrix metalloproteinase-3; DIAGNOSIS; JOINT;
D O I：
10.1111/j.1442-200X.2011.03393.x
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页码：1087 / 1089
页数：3
相关论文
共 50 条
  • [31] Evaluation of serum matrix metalloproteinase-3 as a biomarker for diagnosis of epilepsy
    Wang, Rui
    Zeng, Guang Qun
    Liu, Xu
    Tong, Rui Zhan
    Zhou, Dong
    Hong, Zhen
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 367 : 291 - 297
  • [32] Tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-3 in Japanese healthy children and in Kawasaki disease and their clinical usefulness in juvenile rheumatoid arthritis
    Matsuyama, T
    PEDIATRICS INTERNATIONAL, 1999, 41 (03) : 239 - 245
  • [33] Association of the matrix metalloproteinase-3 (-439C/G) promoter polymorphism with Kawasaki disease in Korean children
    Hong, Young Mi
    Jin, Hyun-Seung
    Park, In Sook
    Hong, Soo-Jong
    HEART AND VESSELS, 2008, 23 (05) : 341 - 347
  • [34] Serum matrix metalloproteinase-3 levels in rheumatoid arthritis and inflammatory diseases without arthritis; Correlation with clinical and laboratory indices of disease activity.
    Sugiyama, E
    Taki, H
    Shinoda, K
    Harada, S
    Kobayashi, M
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S184 - S184
  • [35] Serum levels of matrix metalloproteinase-3 in relation to the development of radiological damage in patients with early rheumatoid arthritis
    Posthumus, MD
    Limburg, PC
    Westra, J
    Cats, HA
    Stewart, RE
    van Leeuwen, MA
    van Rijswijk, MH
    RHEUMATOLOGY, 1999, 38 (11) : 1081 - 1087
  • [36] Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis
    Avdeeva, A. S.
    Aleksandrova, E. N.
    Novikov, A. A.
    Cherkasova, M. V.
    Panasyuk, E. Yu.
    Nasonov, E. L.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (05) : 24 - 29
  • [37] Serum Matrix Metalloproteinase-3 in Comparison with Acute Phase Proteins as a Marker of Disease Activity and Radiographic Damage in Early Rheumatoid Arthritis
    Ally, Mahmood M. T. M.
    Hodkinson, Bridget
    Meyer, Pieter W. A.
    Musenge, Eustasius
    Tikly, Mohammed
    Anderson, Ronald
    MEDIATORS OF INFLAMMATION, 2013, 2013
  • [38] Matrix Metalloproteinase-3 induces proteoglycan degradation in gouty arthritis model
    Shi, Le
    Liang, Tao
    Yang, Fan
    Zhu, Fang-Fang
    Liu, Jin
    Jiang, Jia-Qian
    Wu, Xiao-Wei
    Chen, An-Sheng
    Yuan, Dong-Ping
    Liang, Xin-Li
    GENE, 2021, 765
  • [39] Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients
    Galil, Sahar Mahfouz Abdel
    El-Shafey, Abeer Mohamed
    Hagrass, Hoda A.
    Fawzy, Faten
    El Sammak, Ahmed
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (04) : 377 - 384
  • [40] Association of the matrix metalloproteinase-3 (−439C/G) promoter polymorphism with Kawasaki disease in Korean children
    Young Mi Hong
    Hyun-Seung Jin
    In Sook Park
    Soo-Jong Hong
    Heart and Vessels, 2008, 23 : 341 - 347
12345